Fibrodysplasia Ossificans Progressiva Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
Condition: Fibrodysplasia Ossificans Progressiva Interventions: Drug: IPN60130; Drug: Placebo Sponsors: Clementia Pharmaceuticals Inc.; Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2021 Category: Research Source Type: clinical trials
